CD274 and gastric cancer: Importantly, our results indicated that circulating exosomal PD-L1 in gastric cancer patients increased significantly after two, four, and six cycles of fluoropyrimidine treatment, and the increase in circulating exosomal PD-L1 was more pronounced in non-responders than in responders.